Successful treatment of nocturnal eating/drinking syndrome with selective serotonin reuptake inhibitors

被引:50
作者
Miyaoka, T [1 ]
Yasukawa, R [1 ]
Tsubouchi, K [1 ]
Miura, S [1 ]
Shimizu, Y [1 ]
Sukegawa, T [1 ]
Maeda, T [1 ]
Mizuno, S [1 ]
Kameda, A [1 ]
Uegaki, J [1 ]
Inagaki, T [1 ]
Horiguchi, J [1 ]
机构
[1] Shimane Med Univ, Dept Psychiat, Izumo, Shimane 6938501, Japan
关键词
fluvoxamine; nocturnal eating/drinking disorder (NE/DS); paroxetine; selective serotonin reuptake inhibitor (SSRI);
D O I
10.1097/01.yic.0000068440.56680.8e
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nocturnal eating/drinking disorder (NE/DS) is a rare syndrome that includes disorders of both eating and sleeping. It is characterized by awakening in the middle of the night, getting out of bed, and consuming large quantities of food quickly and uncontrollably, then returning to sleep. This may occur several times during the night. Some patients are fully conscious during their nocturnal eating, while some report total amnesia. The aetiology of NE/DS is still unclear, and there is no satisfactory treatment. Four patients with NE/DS are described. Treatment with a selective seroronin reuptake inhibitor (SSRI) was effective in controlling their episodes of nocturnal eating. To our knowledge, this is the first published case report of successful treatment with SSRIs in NE/DS.
引用
收藏
页码:175 / 177
页数:3
相关论文
共 16 条
[1]  
*AM SLEEP DIS ASS, 1990, INT CLASS SLEEP DIS
[2]  
American Psychiatric Association, 1993, Diagnostic and Statistical Manual of Mental Disorders, V4th
[3]  
[Anonymous], SLEEP RES
[4]  
GREENO CG, 1995, INT J EAT DISORDER, V18, P343, DOI 10.1002/1098-108X(199512)18:4&lt
[5]  
343::AID-EAT2260180407&gt
[6]  
3.0.CO
[7]  
2-P
[8]  
Horiguchi J, 1999, INT CLIN PSYCHOPHARM, V14, P33
[9]   Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa [J].
Kaye, W ;
Gendall, K ;
Strober, M .
BIOLOGICAL PSYCHIATRY, 1998, 44 (09) :825-838
[10]  
MANCINI MC, 1994, REV PAUL MED, V112, P569